Evidence map›Paper›PMID 40974878›Full record

ArticleNeurobiology of aging2025

Association of an in vivo classifier for ARTerioloSclerosis (ARTS) with cortical thickness and cognition in older adults.

Alifiya Kapasi, Maude Wagner, Arnold M Evia, Debra A Fleischman, Patricia Boyle, David Marquez, Lisa L Barnes, David A Bennett, Sue Leurgans, Julie Schneider and 2 more

Abstract read
In one paragraph

Article in Neurobiology of aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. MIND diet, cerebrovascular health, and cognition among community-dwelling older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alifiya KapasiRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Pathology, Chicago, IL, USA. Electronic address: Alifiya_Kapasi@Rush.edu.
Maude WagnerRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA.
Arnold M EviaRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA.
Debra A FleischmanRush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA; Rush University Medical Center, Department of Psychiatry and Behavioral Sciences, Chicago, IL, USA.
Patricia BoyleRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Psychiatry and Behavioral Sciences, Chicago, IL, USA.
David MarquezRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; University of Illinois Chicago, Department of Kinesiology and Nutrition, Chicago, IL, USA.
Lisa L BarnesRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA; Rush University Medical Center, Department of Psychiatry and Behavioral Sciences, Chicago, IL, USA.
David A BennettRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA.
Sue LeurgansRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA.
Julie SchneiderRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Pathology, Chicago, IL, USA; Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA.
Melissa LamarRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Psychiatry and Behavioral Sciences, Chicago, IL, USA.
Konstantinos ArfanakisRush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL, USA; Rush University Medical Center, Department of Diagnostic Radiology and Nuclear Medicine, Chicago, IL, USA; Illinois Institute of Technology, Department of Biomedical Engineering, Chicago, IL, USA.

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Risk Factors for Cognitive Decline in African-AmericansR01AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2004 to 2025
$18.2M
Characterizing the Behavior Profile of Healthy Cognitive AgingR01AG034374 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI PATRICIA A BOYLE · 2009 to 2026
$8.8M
Culturally relevant contributors to cognitive and MRI changes in older LatinosR01AG062711 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI LAMAR, MELISSA · 2020 to 2025
$3.6M
MRI markers of brain aging and risk factors for cognitive decline in older African AmericansR01AG056405 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2018 to 2023
$3.6M
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementiaU01NS100599 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI ARFANAKIS, KONSTANTINOS, SCHNEIDER, JULIE A. · 2023 to 2025
$3.5M
In-vivo MRI-based prediction of TDP43 pathology in agingR01AG064233 · NIA · ILLINOIS INSTITUTE OF TECHNOLOGY · PI ARFANAKIS, KONSTANTINOS, SCHNEIDER, JULIE A. · 2019 to 2023
$3.3M
Small vessel disease contributions to neurodegeneration in Alzheimer's diseaseK01AG075177 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Alifiya Kapasi · 2022 to 2026
$553k
NIA NIH HHS K01 AG075177NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG022018NIA NIH HHS R01 AG034374NIA NIH HHS R01 AG056405NIA NIH HHS R01 AG062711NIA NIH HHS R01 AG064233NINDS NIH HHS U01 NS100599
6 · The paper itself

Abstract

Brain arteriolosclerosis, a prominent small vessel pathology in the aging brain, is associated with cognitive impairment. Understanding the link between arteriolosclerosis and neurodegeneration may be crucial towards unravelling pathways by which arteriosclerosis contributes to cognitive impairment. Using a novel magnetic resonance imaging (MRI) in-vivo classifier for ARTerioloSclerosis termed ARTS, we examined cross-sectional associations between ARTS, cortical thickness, and cognition. Data came from 1054 older participants who were enrolled in one of five ongoing Rush Alzheimer's Disease Center cohort studies, underwent an in-vivo 3 T MRI scan, met the data requirements for ARTS and FreeSurfer processing, and completed cognitive evaluation within a year of MRI. Focusing on the last, most recent MRI scan, we assessed cross-sectional associations of ARTS score with cortical thickness (whole brain and regional measures) and cognitive outcomes (global and domain-specific), using separate linear regression models. Further, we examined whether cortical thickness mediates the relationship between ARTS and global cognition. Models were all adjusted for demographics, vascular risk factors, and scanners. At last analytic MRI scan, participants were on average 80 years old (SD=7) and 80 % were women. Higher ARTS score was associated with lower whole brain cortical thickness (estimate per 1-SD increase=-0.029, 95 % CI: -0.036, -0.022), and across each of the lobes (all P < .01), particularly in temporal lobe regions. Higher ARTS scores were associated with worse global cognition (estimate per 1-SD increase=-0.079, 95 % CI: -0.122, -0.035); also, more specifically higher ARTS score was related to poorer performance in the domains of semantic memory, perceptual speed, and visuospatial ability. In mediation analyses, cortical thickness accounted for 32 % of the association between ARTS score and global cognition. More cerebral arteriolosclerosis-related changes, measured by in-vivo ARTS, is associated with lower cortical thickness and cognitive functions. The association between ARTS and cognition is partially mediated by cortical thickness. Findings suggest that cerebral small vessel disease may contribute to cortical thickness, a marker of neurodegeneration, and contribute both directly and indirectly, to cognitive impairment.

Indexed as

AgingArteriolosclerosisBrain Cortical ThicknessCerebral CortexCognitionCognitive DysfunctionAgedAged, 80 and overCohort StudiesCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleCerebral arteriolosclerosisCognitionCortical thicknessIn-Vivo MRINeurodegenerationSmall vessel disease

Identifiers

PMID40974878
PMCPMC13336035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.